RxSight stock falls after Wells, BTIG downgrade on poor results

4 hours ago 1
Wall Street New York City

aluxum/E+ via Getty Images

RxSight (NASDAQ:RXST) has been downgraded by Wells Fargo and BTIG following a second consecutive quarter of 'disappointing results'.

Wells Fargo cut rating for RSXT to EqualWeight from OverWeight, while BTIG cut rating to Neutral from Buy.

The stock is down

Recommended For You

More Trending News

Read Entire Article